您当前的位置:首页 > 参考文献
 
1.  Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation. Bin Zheng, Joseph H. Jeong, John M. Asara, Yuan-Ying Yuan, Scott R. Granter, Lynda Chin, and Lewis C. Cantley. Molecular cell. 2009 33:237-247. (Product used TMA melanoma tissue).
2.  Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization. Chih-Ping Han, Ming-Yung Lee, Shu-Ling Tzeng, Chung-Chin Yao, Po-Hui Wang, Ya-Wen Cheng, Show-Li Chen, Teresa S Wu, Yeu-Sheng Tyan, and Lai-Fong Kok. J Exp Clin Cancer Res.. 2008 27(1):25. (Product used TMA BCN962).
3.  Transforming Growth Factor-B1 Promotes Matrix Metalloproteinase-9�CMediated Oral Cancer Invasion through Snail Expression. Limin Sun, Michelle E. Diamond, Adam J. Ottaviano, Mathew J. Joseph, Vijayalakshmi Ananthanarayan, and Hidayatullah G. Munshi. Mol Cancer Res. 2008 6(1):. (Product used TMA Oral cancer microarrays).
4.  BNIP3L (Nix) expression in colon cancer . J. E. Littlejohn, D. Jupiter, X. Cao, L. Zhang, M. Shabahang, W. R. Smythe; Texas A&M Health Science Center College of Medicine, Temple, TX. J Clin Oncol . 2009 27:. (Product used TMA CO701).  
5.  A Regulatory Mechanism for RSK2 NH2-Terminal Kinase Activity. Yong-Yeon Cho, Ke Yao, Angelo Pugliese, Margarita L. Malakhova, Ann M. Bode and Zigang Dong . Cancer Research. 2009 69(10):4398-4406. (Product used TMA SK801).
6.  Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. Julie Guillermet-Guibert, Lise Davenne, Dimitri Pchejetski, Nathalie Saint-Laurent, Leyre Brizuela, C??line Guilbeau-Frugier, Marie-Bernadette Delisle, Olivier Cuvillier, Christiane Susini1 and Corinne Bousquet. Mol Cancer Ther . 2009 8:809. (Product used TMA pancreatic tissue array ).
7.  Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells. Anuraag Shrivastav, Shailly Varma, Arnie Senger, Ramji L Khandelwal, Svein Carlsen, Rajendra K Sharma . The Journal of Pathology. 2009 :. (Product used TMA BR802).
8.  Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer. Takeo Fujita, Hirokuni Ikeda, Naruto Taira, Shinji Hatoh, Minoru Naito and Hiroyoshi Doihara. BMC Cancer . 2009 9:87. (Product used TMA Colon).
9.  Overexpression and Mislocalization of the Chromosomal Segregation Protein Separase in Multiple Human Cancers. Rene Meyer, Viacheslav Fofanov, AnilK. Panigrahi, Fatima Merchant, Nenggang Zhang and Debananda Pati . Clinical Cancer Research. 2009 15:2703. (Product used TMA BS26011).
10.  Novel Breast Cancer Metastasis-Associated Proteins. Jiapei Ho, Jacklyn-Wai-Fun Kong, Lee-Yee Choong, Marie-Chiew-Shia Loh, Weiyi Toy, Poh-Kuan Chong, Chee-Hong Wong, Chow-Yin Wong, Nilesh Shah and Yoon-Pin Lim. J. Proteome Res.. 2009 8 (2):583?C594. (Product used TMA Breast).
11.  Fibroblast Growth Factor Receptor 1?CTransformed Mammary Epithelial Cells Are Dependent on RSK Activity for Growth and Survival. Wa Xian, Leontios Pappas, Darshan Pandya, Laura M. Selfors, Patrick W. Derksen, Michiel de Bruin, Nathanael S. Gray, Jos Jonkers, Jeffrey M. Rosen and Joan S. Brugge. Cancer Research. 2009 69:2244. (Product used TMA BR805 BR809).
12.  Role of CCL11/eotaxin-1 signaling in ovarian cancer. Vera Levina, Brian M. Nolen, Adele M. Marrangoni, Peng Cheng, Jeffrey R. Marks, Miroslaw J. Szczepanski, Marta E. Szajnik, Elieser Gorelik, and Anna E. Lokshin. Clin Cancer Res.. 2009 15:2647-2656. (Product used TMA ovarian).
13.  Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression. Adam S. Feldman, Jacqueline Banyard, Chin-Lee Wu, W. Scott McDougal and Bruce R. Zetter. Clinical Cancer Research. 2009 15:1024. (Product used TMA BL801).
14.  IL15 Can Reverse the Unresponsiveness of Wilms' Tumor Antigen-Specific CTL in Patients with Prostate Cancer. Judy W. King, Sharyn Thomas, Fabrizio Corsi, Liquan Gao, Roberto Dina, Roopinder Gillmore, Katharine Pigott, Amir Kaisary, Hans J. Stauss and Jonathan Waxman. Clinical Cancer Research. 2009 15:1145. (Product used TMA ).
15.  AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001. Marin Marinov, Algirdas Ziogas, Olivier. Pardo, Liwen Terence Tan, Tony Dhillon, Francesco A. Mauri, Heidi A. Lane, Nicholas R. Lemoine, Uwe Zangemeister-Wittke, Michael J. Seckl and Alexandre Arcaro. Clinical Cancer Research. 2009 15:1277. (Product used TMA BN04011 BS04111).
16.  Smad Ubiquitination Regulatory Factor 2 Promotes Metastasis of Breast Cancer Cells by Enhancing Migration and Invasiveness. Chaoyang Jin, Yu-an Yang, Miriam R. Anver, Nicole Morris, Xiangchun Wang and Ying E. Zhang. Cancer Research. 2009 69:735. (Product used TMA BR801).
17.  Transient Receptor Potential Type Vanilloid 1 Suppresses Skin Carcinogenesis. Ann M. Bode, Yong-Yeon Cho, Duo Zheng, Feng Zhu, Marna E. Ericson, Wei-Ya Ma, Ke Yao and Zigang Dong. Cancer Research. 2009 69:905. (Product used TMA Skin).
18.  Aberrant Promoter Methylation of Sparc in Ovarian Cancer. Matthew J. Socha, Neveen Said, Yanshan Dai, Joseph Kwong, Preetha Ramalingam, Vuong Trieu, Neil Desai, Samuel C. Mok and Kouros Motamed. NEOplasia. 2009 11(2):126-135. (Product used TMA OV801 OV2001).
19.  cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation. LINNERTH, N. M.; GREENAWAY, J. B.; PETRIK, J. J.; MOOREHEAD, R. A.. International Journal of Gynecological Cancer. 2009 18(6):1248-1257. (Product used TMA Ovarian).
20.  Aberrant Prothymosin-alpha Expression in Human Bladder Cancer. Yuh-Shyan Tsai, Yeong-Chin Jou, Gia-Fong Lee, Yeong-Chang Chen, Ai-Li Shiau, Hsin-Tzu Tsai, Chao-Liang Wu, Tzong-Shin Tzai. Basic and Translational Science. 2009 73(1):189-192. (Product used TMA BL241 BL801).
21.  Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization. Chih-Ping Han, Ming-Yung Lee, Shu-Ling Tzeng, Chung-Chin Yao, Po-Hui Wang, Ya-Wen Cheng, Show-Li Chen, Teresa S Wu, Yeu-Sheng Tyan, and Lai-Fong Kok. J Exp Clin Cancer Res.. 2008 27(1):25. (Product used TMA BCN962).
22.  Transforming Growth Factor-B1 Promotes Matrix Metalloproteinase-9?CMediated Oral Cancer Invasion through Snail Expression. Limin Sun, Michelle E. Diamond, Adam J. Ottaviano, Mathew J. Joseph, Vijayalakshmi Ananthanarayan, and Hidayatullah G. Munshi. Mol Cancer Res. 2008 6(1):. (Product used TMA Oral cancer microarrays).
23.  Feedback Regulation between Zipcode Binding Protein 1 and ?­Catenin mRNAs in Breast Cancer Cells. Wei Gu, Amber L. Wells, Feng Pan, and Robert H. Singer. Molecular and Cellular Biology. 2008 28(16):4963-4974. (Product used TMA Breast).
24.  Sox7 Is an Independent Checkpoint for β-Catenin Function in Prostate and Colon Epithelial Cells. Lizheng Guo, Diansheng Zhong, Stephen Lau, Xiuju Liu, Xue-Yuan Dong, Xiaodong Sun, Vincent W. Yang, Paula M. Vertino, Carlos S. Moreno, Vijay Varma, Jin-Tang Dong and Wei Zhou. Cancer Genes and Genomics. 2008 6:1421-1430. (Product used TMA Prostate and Colorectal Cancer).
25.  Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival. Chun-Liang Chen, Ling Cen, Jennifer Kohout, Brian Hutzen, Christina Chan, Fu-Chuan Hsieh, Abbey Loy, Victor Huang, Gong Cheng and Jiayuh Lin. Molecular Cancer. 2008 7:78-89. (Product used TMA Bladder).
26.  Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression. Nawfal I Ismail, Gurjeet Kaur, Hasnah Hashim, and Mohammed S Hassan. Cancer Cell Int.. 2008 8:6. (Product used TMA BR1001, BR2001).
27.  Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer. Kiwon Lee, Yin Liu, Jun Qin Mo, Jinsong Zhang, Zhongyun Dong and Shan Lu. BMC Cancer. 2008 8:158. (Product used TMA Breast).
28.  Identification of interleukin-13 receptor a2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma. "Bharat H. Joshi, Rada A. Puri, Pamela Leland, Frederick Varricchio, Ghanshyam Gupta,. . :. (Product used ).
29.  Mehmet Kocak, Richard J. Gilbertson, and Raj K. Puri,". 2008. http://neuro-oncology.dukejournals.org/cgi/reprint/10/3/265.pdf. 10 265-274:Neuro-Oncology. (Product used Brain 2009-2-3).
30.  Fluorophore-conjugated anti-CEA Antibody for the Intraoperative Imaging of Pancreatic and Colorectal Cancer. Sharmeela Kaushal, Michele K. McElroy, George A. Luiken, Mark A. Talamini, A. R. Moossa, Robert M. Hoffman and Michael Bouvet. Journal of Gastrointestinal Surgery. 2008 12:1938-1950. (Product used TMA Colon).
31.  Dissection of the APCCdh1-Skp2 Cascade in Breast Cancer. Takeo Fujita, Weijun Liu, Hiroyoshi Doihara, Hiroshi Date and Yong Wan. Clinical Cancer Research. 2008 14:1966-1975. (Product used TMA Breast).
32.  ssDNA-Binding Protein 2 Is Frequently Hypermethylated and Suppresses Cell Growth in Human Prostate Cancer. Jun-Wei Liu, Jatin K. Nagpal, Wenyue Sun and Juna Lee. Clinical Cancer Research. 2008 14:3754-3760. (Product used TMA Prostate cancer).
33.  Monoclonal Antibody CC188 Binds a Carbohydrate Epitope Expressed on the Surface of Both Colorectal Cancer Stem Cells and their Differentiated Progeny. Mai Xu, Yuan Yuan, Yang Xia and Samuel Achilefu. Clinical Cancer Research. 2008 14:7461-7469. (Product used TMA ).
34.  Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation. Jian Teng, Zun-Yi Wang, David F Jarrard and Dale E Bjorling. Endocr Relat Cancer. 2008 15:351-364. (Product used TMA BC19111, PR801).
35.  A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene. Stephane Gobeil, Xiaochun Zhu, Charles J. Doillon, and Michael R. Green. Genes & Dev.. 2008 22:2932-2940. (Product used TMA ME1001).
36.  Identification of a Core Set of 58 Gene Transcripts With Broad and Specific Expression in the Microvasculature. Elisabet Wallgard; Erik Larsson; Liqun He; Mats Hellström; Annika Armulik; Maya H. Nisancioglu; Guillem Genove; Per Lindahl; Christer Betsholtz . Arteriosclerosis, Thrombosis, and Vascular Biology. 2008 28:1469. (Product used TMA ).
37.  CX3CR1 Is Expressed by Prostate Epithelial Cells and Androgens Regulate the Levels of CX3CL1/Fractalkine in the Bone Marrow: Potential Role in Prostate Cancer Bone Tropism. Whitney L. Jamieson, Saori Shimizu, Julia A. D'Ambrosio1, Olimpia Meucci1 and Alessandro Fatatis. Cancer Research. 2008 68:1715-1722. (Product used TMA Prostate).
38.  Cyclin-Dependent Kinase 3–Mediated Activating Transcription Factor 1 Phosphorylation Enhances Cell Transformation. Duo Zheng, Yong-Yeon Cho, Andy T.Y. Lau, Jishuai Zhang, Wei-Ya Ma, Ann M. Bode and Zigang Dong . Cancer Research. 2008 68:7650-7660. (Product used TMA ).
39.  Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Anindita Bhoumik, Boris Fichtman, Charles DeRossi, Wolfgang Breitwieser, Harriet M. Kluger, Sean Davis, Antonio Subtil, Paul Meltzer, Stan Krajewski, Nic Jones, and Ze'ev Ronai. PNAS. 2008 105:1674-1679 . (Product used TMA Skin).
40.  Regulation of Skp2-p27 Axis by the Cdh1/Anaphase-Promoting Complex Pathway in Colorectal Tumorigenesis. Takeo Fujita, Weijun Liu, Hiroyoshi Doihara and Yong Wan. American Journal of Pathology. 2008 173:217-228. (Product used TMA Colon).
41.  Regulatory effect of nerve growth factor in {alpha}9β1 integrin–dependent progression of glioblastoma. Meghan C. Brown, Izabela Staniszewska, Philip Lazarovici, George P. Tuszynski, Luis Del Valle and Cezary Marcinkiewicz . Neuro Oncol. 2008 10(6):968-980. (Product used TMA Brain).
42.  Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression . Kristina E. Hoot, Jessyka Lighthall, Gangwen Han, Shi-Long Lu, Allen Li, Wenjun Ju, Molly Kulesz-Martin, Erwin Bottinger and Xiao-Jing Wang. J. Clin. Invest. 2008 118(8):2722-2732. (Product used TMA ).
43.  Calcification of Multipotent Prostate Tumor Endothelium . Andrew C. Dudley, Zia A. Khan, Shou-Ching Shih, Soo-Young Kang, Bernadette M.M. Zwaans, Joyce Bischoff and Michael Klagsbrun. Cancer Cell. 2008 14(3):201-211. (Product used TMA Prostate cancer).
44.  Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice. R . Wang , K . Sengupta , C . Li , H . Kim , L . Cao , C . Xiao , S . Kim , X . Xu , Y . Zheng , B . Chilton. Cancer Cell. 2008 14(4):312 - 323. (Product used TMA TMA).
45.  The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development . Tyson V. Sharpa, Ahmad Al-Attarb, Daniel E. Foxlera, Li Dingc, Thomas Q. de A. Vallima, Yining Zhanga, Hala S. Nijmeha, Thomas M. Webba, Andrew G. Nicholsond, Qunyuan Zhange, Aldi Krajae, Ian Spendloveb, John Osbornec, Elaine Mardisc, and Gregory D. Longmoref . PANS. 2008 15(50):9932-19937. (Product used ).
46.  Loss of interferon-γ inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation. Meissner, M.; Whiteside, T.L.; van Kuik-Romein, P.; Valesky, E.M.; van den Elsen, P.J.; Kaufmann, R.; Seliger, B. . British Journal of Dermatology. 2008 158(5):930-940. (Product used TMA ).
47.  Overexpression of the αvβ6 Integrin in Endometrial Cancer. Hecht, Jonathan L. MD, PhD; Dolinski, Brian M.; Gardner, Humphrey A. MD; Violette, Shelia M. PhD; Weinreb, Paul H. PhD. Applied Immunohistochemistry & Molecular Morphology. 2008 16(6):543-547. (Product used TMA ).
48.  Overexpression of the [alpha]v[beta]6 Integrin in Endometrial Cancer. Hecht, Jonathan L. MD, PhD; Dolinski, Brian M.; Gardner, Humphrey A. MD; Violette, Shelia M. PhD; Weinreb, Paul H. PhD . Applied Immunohistochemistry & Molecular Morphology. 2008 16(6):543-547. (Product used TMA Endometral carcinoma).
49.  Dickkopf-3 as a new potential marker for neoangiogenesis in colorectal cancer: Expression in cancer tissue and adjacent non-cancerous tissue. Matthias Zitt, Gerold Untergasser, Albert Amberger. Disease Markers. 2008 24(2):101-109. (Product used TMA Colon cancer).
50.  Hedgehog Signaling Regulates Brain Tumor Initiating Cell Proliferation and Portends Shorter Survival for Patients with PTEN-Coexpressing Glioblastomas . Qijin Xu, Xiangpeng Yuan, Gentao Liu, Keith L. Black, John S Yu. Stem Cells. 2008 26(12):3018-3026. (Product used TMA Brain).
51.  SmgGDS Regulates Cell Proliferation, Migration, and NF-kappa B Transcriptional Activity in Non-small Cell Lung Carcinoma. Gaik Wei Tew1, Ellen L. Lorimer, Tracy J. Berg, Huiying Zhi, Rongshan Li, and Carol L. Williams. J. Biol. Chem. 2008 283(2):963-976. (Product used TMA Lung).
52.  Regulation of 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) by Src Involves Tyrosine Phosphorylation of PDK1 and Src Homology 2 Domain Binding. Keum-Jin Yang, Sanghee Shin, Longzhen Piao, Eulsoon Shin, Yuwen Li, Kyeong Ah Park, Hee Sun Byun, Minho Won, Janghee Hong, Gi Ryang Kweon, Gang Min Hur, Jeong Ho Seok, Taehoon Chun, Derek P. Brazil, Brian A. Hemmings, and Jongsun Park. J. Biol. Chem. 2008 283(3):1480-1491. (Product used TMA ).
53.  Fibulin-5 initiates epithelial–mesenchymal transition (EMT) and enhances EMT induced by TGF-β in mammary epithelial cells via a MMP-dependent mechanism . Yong-Hun Lee, Allan R. Albig, MaryAnn Regner, Barbara J. Schiemann and William P. Schiemann . Carcinogenesis. 2008 29(12):2243-2251. (Product used TMA BR241).
54.  In Virto and In Vivo Photosensitizing Applications of Photofrin in Malignant Melanoma Cells. Cheng-Jen Chang, Jau-Song Yu, Fu-Chan Wei. Chang Guang Med J. 2008 31(3):260-267. (Product used TMA Skin).
55.  Immunohistochemical determination of the P15INK4b protein expression in cutaneous squamous cell carcinoma. Ahmed I. Moad, Tan Mei Lan, Gurjeet Kaur, Hasnah Hashim, Mohamed J. E. M. F. Mabruk . Journal of Cutaneous Pathology. 2008 36(2):183-189. (Product used TMA ).
56.  Endo180 expression with cofunctional partners MT1-MMP and uPAR–uPA is correlated with prostate cancer progression. Giolanta Kogianni, Marjorie M. Walker, Jonathan Waxman and Justin Sturge. European Journal of Cancer. 2008 45(4):685-693. (Product used TMA PR951 PR952).
57.  Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers. G P Skliris, F Hubé, I Gheorghiu, M M Mutawe, C Penner, P H Watson, L C Murphy, E Leygue, and Y Myal. Histopathology. 2008 52(3):355-369. (Product used TMA BN08013).
58.  Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers. Skliris, G P; Hube, F; Gheorghiu, I; Mutawe, M M; Penner, C; Watson, P H; Murphy, L C; Leygue, E; Myal, Y. Histopathology. 2008 52(3):355-369. (Product used TMA ).
59.  Expression and sub-cellular localization of the CCAAT/enhancer binding protein in relation to postnatal development and malignancy of the prostate. Juan Zhang, John Erby Wilkinson, Mesfin Gonit, Rick Keck, Steven Selman, Manohar Ratnam . The Prostate. 2008 68(11):1206-1214. (Product used TMA PR802 PR952 BC19111).
60.  S100A4 overexpression proves to be independent marker for breast cancer progression. Nawfal I Ismail, Gurjeet Kaur, Hasnah Hashim and Mohammed S Hassan. Cancer Cell International. 2008 8(12):1Ԃ6ȕ. (Product used TMA BR2001).
61.  BK Virus as a Cofactor in the Etiology of Prostate Cancer in Its Early Stages. Dweepanita Das, Kirk Wojno and Michael J. Imperiale. J of Virology. 2008 82(6):2705-2714. (Product used TMA Normal Prostate).
62.  Current Topics in Human Genetics: Studies in Complex Diseases. Hong-Wen Deng, Hui Shen, Yong-Jun Liu. World Scientific. 2008 :475. (Product used ).
63.  BKV as a Cofactor in the Etiology of Prostate Cancer in its Early Stages. Dweepanita Das, Kirk Wojno and Michael J. Imperiale. J. Virol.. 2007 :. (Product used TMA Prostate).
64.  A Suppressive Role of the Prolyl Isomerase Pin1 in Cellular Apoptosis Mediated by the Death-associated Protein Daxx . Akihide Ryo, Akiko Hirai, Mayuko Nishi, Yih-Cherng Liou, Kilian Perrem, Sheng-Cai Lin, Hisashi Hirano, Sam W. Lee, and Ichiro Aoki. THE JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 282(50):36671?C36681. (Product used TMA Glioma).
65.  Genome-wide DNA copy number analysis in pancreatic cancer using. T Harada, C Chelala, V Bhakta, T Chaplin, K Caulee, P Baril, BD Young and NR Lemoine. Oncogene (online publication). 2007 1:1Ԃ10ȕ. (Product used TMA PA801).
66.  Increased Expression of the Collagen Internalization Receptor uPARAP/Endo180 in the Stroma of Head and Neck Cancer. Jay Sulek , Rebecca A. et all. J Histochem Cytochem. 2007 55:00:00:347‿53. (Product used TMA Head and Neck).
67.  Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts. Alice P. Taylor and David M. Goldenberg. Molecular Cancer Therapeutics. 2007 6:524-531. (Product used TMA Breast).
68.  Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. Rosalyn D Blumenthal et al. BMC Cancer. 2007 7:2. (Product used TMA BR1001, CO991 and LC801).
69.  The Ubiquitin-Conjugating Enzyme E2-EPF Is Overexpressed in Primary Breast Cancer and Modulates Sensitivity to Topoisomerase II Inhibition. Donato Tedesco et el. Neoplasia. 2007 9:601-613. (Product used TMA BR701).
70.  Smad3 Is Overexpressed in Advanced Human Prostate Cancer and Necessary for Progressive Growth of Prostate Cancer Cells in Nude Mice. Shan Lu, Juwon Lee, Monica Revelo, Xiaohong Wang, Shan Lu and Zhongyun Dong. Clinical Cancer Research. 2007 13:5692-5702. (Product used TMA Prostate).
71.  Selective Down-Regulation of Glioma-Associated Oncogene 2 Inhibits the Proliferation of Hepatocellular Carcinoma Cells. Youngsoo Kim, Joon Won Yoon, Xiaokun Xiao, Nicholas M. Dean, Brett P. Monia and Eric G. Marcusson . Cancer Research. 2007 67:3583-3593. (Product used TMA Liver).
72.  Tumor Necrosis Factor Receptor 1/c-Jun-NH2-Kinase Signaling Promotes Human Neoplasia. Jennifer Y. Zhang, Amy E. Adams, Todd W. Ridky, Shiying Tao and Paul A. Khavari . Cancer Research. 2007 67:3827-3834. (Product used FFPE Sections Skin Squamous Carcinoma).
73.  AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts. Jing Zhang, et al. J. Clin. Invest. 2007 117:2962-2973. (Product used TMA BC19111).
74.  A novel biomarker for the detection of esophageal adenocarcinoma. Zane T. Hammoud, et al. J Thorac Cardiovasc Surg. 2007 133:82-87. (Product used TMA Esophagus).
75.  Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Michael E. Hudson, Irina Pozdnyakova, et al. PANS. 2007 104 (44)::17494-17499. (Product used TMA OR601).
76.  CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Zhenhua Miao, et al. PNAS. 2007 104(40):15735-15740. (Product used TMA ).
77.  Overexpressed Raf-1 and phosphorylated cyclic adenosine 3-5-monophosphatate response element-binding protein are early markers for lung adenocarcinoma. Maria Cekanova, et al. Cancer. 2007 109(6):1164-1173. (Product used TMA LC1002).
78.  Quantitative hypermethylation of NMDAR2B in human gastric cancer. Jun-Wei Liu, et al. International Journal of Cancer. 2007 121(9):1994-2000. (Product used TMA Stomach).
79.  Mammaglobin vs GCDFP-15: An Immunohistologic Validation Survey for Sensitivity and Specificity. Rohit Bhargava et al. Am J Clin Pathol.. 2007 127(1):103-113. (Product used TMA ).
80.  Dickkopf-3 is expressed in a subset of adult human pancreatic beta cells. H. Hermman, et al. Histochemistry and Cell Biology. 2007 127(5):513-521. (Product used Tissue section Pancreas).
81.  Haplotypes, Loss of Heterozygosity, and Expression Levels of Glycine N-Methyltransferase in Prostate Cancer. Yu-Chuen Huang, Cheng-Ming Lee, Marcelo Chen, Ming-Yi Chung, Yen-Hwa Chang, William Ji-Shian Huang, Donald Ming-Tak Ho, Chin-Chen Pan, Tony T. Wu, Stone Yang, Ming-Wei Lin, Jer-Tsong Hsieh and Yi-Ming Arthur Chen. Clinical Cancer Research. 2007 13(5):1412-1420. (Product used TMA Prostate).
82.  Association of Nuclear, Cytoplasmic Expression of Galectin-3 With β-Catenin/Wnt-Pathway Activation in Thyroid Carcinoma. Paul M. Weinberger, MD; Bao-Ling Adam, PhD; Christine G. Gourin, MD; William H. Moretz III, MD; Roni J. Bollag, MD, PhD; Beverly Y. Wang, MD; Zhongmin Liu, PhD; Jeffrey R. Lee, MD; David J. Terris, MD. Arch Otolaryngol Head Neck Surg.. 2007 133(5):503-510. (Product used TMA TH802).
83.  Expression of matrix metalloproteinases (MMP1, 2, 9, and 11) in metastatic lymph node tissue of breast cancer patients.. A. Fink-Retter et al. Journal of Clinical Oncology. 2007 25 (8S)::21138. (Product used TMA BR1001).
84.  Lobular Versus Ductal Breast Neoplasms: The Diagnostic Utility of P120 Catenin. Dabbs, David J.; Bhargava, Rohit; Chivukula, Mamatha . American Journal of Surgical Pathology. 2007 31(3):427-437. (Product used TMA Breast Cancer).
85.  high-density single nucleotide polymorphism arrays. Dabbs, David and Bhargava, Rohit . American Journal of Surgical Pathology. 2007 31(3)::427-437. (Product used TMA Breast).
86.  Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue (Abstract). Christoph Zenzmaier, Gerold Untergasser, Martin Hermann, Stephan Dirnhofer, Natalie Sampson, Peter Berge. The Prostate (Wiley-Liss, Inc., A Wiley Company). 2007 68(5):540 - 547. (Product used TMA PR802).
87.  The human papillomavirus type 16 E7 oncoprotein activates the Fanconi Anemia (FA) pathway and causes accelerated chromosomal instability in FA cells. Nicole Spardy, Anette Duensing, Domonique Charles, et al. J. Virol. 2007 81 (23):13265-13270. (Product used TMA CR801).
88.  Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells. Philip L. Lorenzi, et al. Mol Cancer Ther.. 2006 5:2613-2623. (Product used TMA OV2001).
89.  Association of insulin-like growth factor binding protein-3 expression with melanoma progression. Yaguang Xi, et al. Mol Cancer Ther. . 2006 5:3078-3084. (Product used TMA ).
90.  Molecular Profiling of ADAM12 in Human Bladder Cancer. Camilla Fröhlich et al. Clinical Cancer Research . 2006 12:7359-7368. (Product used TMA BC12011, BL801,. and BC12012).
91.  CYP2A13 in Human Respiratory Tissues and Lung Cancers: An Immunohistochemical Study with A New Peptide-Specific Antibody. Liang-Ru Zhu et all. Drug Metabolism and Disposition. 2006 34:1672-1676. (Product used Tissue section HuFPT111 and 131).
92.  A role for the G12 family of heterotrimeric G-proteins in prostate cancer invasion. Patrick Kelly, Laura N. Stemmle. et al. J. Biol. Chem. 2006 36:26483-26490. (Product used TMA BR801).
93.  Increased Levels of the FoxM1 Transcription Factor Accelerate Development and Progression of Prostate Carcinomas in both TRAMP and LADY Transgenic Mice. Tanya V. Kalin et al. Cancer Research . 2006 66:1712-1720. (Product used TMA Prostate).
94.  The Forkhead Box m1 Transcription Factor Stimulates the Proliferation of Tumor Cells during Development of Lung Cancer. Il-Man Kim, et al. Cancer Research . 2006 66:2153-2161. (Product used TMA LC1001).
95.  Tyrosine Kinase Etk/BMX Is Up-regulated in Human Prostate Cancer and Its Overexpression Induces Prostate Intraepithelial Neoplasia in Mouse. Bojie Dai, et al. Cancer Research. 2006 66:8058-8064. (Product used TMA BC19111, PR801, and PR802).
96.  "The G12 family of heterotrimeric G proteins promotes. . . :. (Product used ).
97.  breast cancer invasion and metastasis". Patrick Kelly, et al. PNAS. 2006 103(21):8173-8178. (Product used TMA BR801).
98.  A critical role for IκB kinase α in the development of human and mouse squamous cell carcinomas. Bigang Liu, et all. Proc Natl Acad Sci U S A. 2006 103(46):17202-17207. (Product used TMA SK801, SK802).
99.  Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Jongdae Lee, Christina C. N. Wu, Ki Jeong Lee, Tsung-Hsien Chuang, Kyoko Katakura, Yu-Tsueng Liu, Michael Chan, Rommel Tawatao, Michelle Chung, Carol Shen, Howard B. Cottam, Michael M. C. Lai, Eyal Raz, and Dennis A. Carson . PNAS. 2006 103(6):1828-1833. (Product used TMA ).
100.  "Links between -catenin, NF- B, and squamous. . . :. (Product used ).
101.  cell carcinoma in skin". Agnieszka Kobielak and Elaine Fuchs*. PNAS. 2006 103(7):2322-2327. (Product used TMA hSCC).
102.  Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism. Christian F Singer, Anneliese Fink-Retter, Daphne Gschwantler-Kaulich, Theresia Thalhammer, Gernot Hudelist, Ruth Mueller, Klaus Czerwenka and Ernst Kubista. Endocrine-Related Cancer. 2006 13(4):1101-1107. (Product used TMA Breast).
103.  "Isoform-specific regulation of UDP-glucuronosyltransferase (UGT)2B. . . :. (Product used ).
104.  enzymes in the human prostate: differential consequences for androgen and. . . :. (Product used ).
105.  bioactive lipid inactivation". Sarah Chouinard, et al. Endocrinology. 2006 147(11):5431-5442. (Product used TMA Prostate).
106.  Vav3 Oncogene Is Overexpressed and Regulates Cell Growth and Androgen Receptor Activity in Human Prostate Cancer. Zhongyun Dong et al. Molecular Endocrinology . 2006 20(10):2315-2325. (Product used TMA PR801, PR802).
107.  WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Lynne Bingle, et al. Respiratory Research . 2006 7(1):61. (Product used TMA LC801).
108.  Secretagogin Is a Novel Marker for Neuroendocrine Differentiation. Karin Birkenkamp-Demtröder, et al. Neuroendocrinology. 2005 82:121-138. (Product used TMA Glioblastoma EN801).
109.  Il-Man Kim, Timothy Ackerson, Sneha Ramakrishna, et al.. The Forkhead Box m1 Transcription Factor Stimulates the Proliferation of Tumor Cells during Development of Lung Cancer. Cancer Res.2006; 66: 2153-2161
110.  Zhongyun Dong, Yin Liu, Shan Lu, Amy Wang, et al., Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer. Molecular Endocrinology. June 8, 2006
111.  Agnieszka Kobielak and Elaine Fuchs. Links between {alpha}-catenin, NF-{kappa}B, and squamous cell carcinoma in skin. PNAS2006;103;2322-2327. Feb 1, 2006
112.  Lynne Bingle, Simon S Cross, Alec S High, William A Wallace, et al. WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respiratory Research. April 06, 2006
113.  Rubin MA. Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate Cancer. J. Pathol.195(1): 80-86. (2001)
114.  Kallioniemi OP, Wagner U , Kononen J, et al. Tissue microarray technology for high-throughput molecular profiling of cancer. Human Molecular Genetics, 10(7): 657-662. (2001)
115.  Eggeling FV, Davies H,Lomas L, , et al. Tissue-specific microdissection coupled with proteinchip array technologies: applications in cancer research. BioTechniques, 29(5): 1066-1070. (2000)
116.  Watson SJ, Akil H. Gene chops and arrays revealed: a primer on their power and their rses[J]. Biol Psychiatry, 45(5):533-543. (1999)
117.  Marshall A, Hodgson J. DNA chips: an array of possibilities[J]. Nat Biotechnol, 16(1): 27-31. (1998)
118.  Battifora H. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest, 55(1):244-248. (1986)
119.  Kononen J, Bubendorf L, Kallionieni A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Med, 4(7): 844-847. (1998)
120.  amplification and overexpression in urinary bladder cancer.Am society invest pathol, 157(3): 787-794. (2000)
121.  Moch H, Lononen J, Kallioniemi OP, et al. Tissue microarray: what will they bring to molecular and a Richter J,Wagner U,Kononen J,et al. High-throughput tissue microarray analysis of cyclin E gene natomic pathology? Advan Anato Pathol, 8(1):14-20. (2001)
122.  Hoos A,Urist MJ,Stojadinovic A,et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol, 158(4):1245-1251. (2001)
123.  Schraml P,Struckmann K,Bednar R,et al. CDKN2A mutation analysis, protein expression ,and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas. Am J Pathol, 158(2):593-601. (2001
124.  Miettinen HE, Jrvinen TAH, Kellner U, et al. High topoisomerase Ⅱα exprassion associates with high proliferation rate and poor prognosis in pligodendrogliomas. Neuropathol Appli Neurobiol, 26(6):504-512. (2000)
125.  Bowen C, Bubendorf L, James Voeller H, et al. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res, 60(1):6111-6115. (2000)
126.  Mucci NR, Akdas G, Manely S, et al. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Human Pathol, 31(4):406-414. (2000)
127.  Perrone EE, Theoharis C, Mucci NR, et al. Tissue microarray assessment of prostate cancer tumor proliferation in African-American and white men. J Natl Cancer Inst, 92(11):937-939. (2000)
128.  Chaib H, Rubin MA, Mucci NR, et al. Activated in Prostate Cancer: a PDZ Domain-Containing Protein Highly Expressed in Human Primary Prostate Tumors. Cancer Res, 61(6): 2390-2394. (2001)
129.  Bubendorf L,Kononen J,Koivisto P,et al. Survey of amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res, 59(2):803-806.(1999)
130.  Schraml P,Kononen J,Bubendorf L,et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res, 5(5):1966-1975. (1999)
131.  Simon R,Richter J,Wagner U,et al.High-throughput tissue microarray analysis of 3p25(RAF1) and 8p12(FGFR1) copy number alterations in urinary bladder cancer. Cancer Res, 61(12):4514-4519. (2001)
132.  Gillett CE, Springall RJ, Bames DM, et al. Multiple tissue core arrays in histopathology research: a validation study. J Pathol, 192(2):549-553. (2000)
133.  Barlund M, Monni O, Kononen J, et al. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. 60(19):5340-5344. (2000)
134.  Barlund M, Forozan F, Kononen J, et al. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst, 92(15):1252-1259. (2000)
135.  Moch H, Schraml P, Bubendorf L, et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. J Path, 154(4):981-986. (1999)
136.  Bubeudorf L, Kolmer M, Kononen J, et al. Molecular mechanisms of hormone therapy failure in human prostate cancer analysed by a combination of cDNA and tissue microarrays. J Natl Cancer Inst, 91(20): 1758-1764. (1999)
137.  Hedenfalk I,Duggan D,Chen Y,et al. Gene-expression profiles in hereditary breast cancer. New Engl J Med, 344(8): 539-548. (2001)
138.  Bubendorf L,Nocito A,Moch H,et al. Tissue microarray(TMA) technology:miniaturized pathology archives for high-throughput in situ studies. J Pathol, 195(1):72-79. (2001)

 

 

 

----------------------------------------------------------------------------------------------------------------------------------------------
Copyright © 2000 - 2018 Cybrdi. All Rights Reserved
版权所有:陕西超英生物科技有限公司
陕ICP备05001565号